Psoriasis in Pakistani population: Associations, comorbidities, and hematological profile
Keywords:
Psoriasis, clinical features, associations, comorbidities, hematological profile, hemoglobin, ESR, uric acidAbstract
Objective To observe the clinical features, laboratory profile, associations and comorbidities of psoriasis in a segment of Pakistani population. Patients and methods This cross-sectional descriptive study was carried out at PAF base hospital, Sargodha from January 2010 to December 2010. One hundred consecutive patients with a diagnosis of psoriasis were included in the study. The diagnosis was confirmed by one of the consultant dermatologists. Pretested, especially designed questionnaire was filled by all the participating patients. Information regarding age, sex, duration of disease, clinical type and severity of disease, nail and joint involvement, koebnerization, associated diseases, and hematological profile including hemoglobin level, blood ESR, uric acid level and its association with joint involvement were recorded. Results Out of the 100 consecutive patients included in the study, 71 were males and 29 were females. Mean age of onset was 39.8 years. 88 patients had chronic plaque psoriasis, 8 had guttate and 4 had erythrodermic psoriasis. 46 patients had some sort of joint involvement and 29 patients had some sort of nail involvement. Only 14 patients gave history of koebnerization. Only 10 patients had associated skin disease while 15 patients had some associated medical disease. Mean hemoglobin levels were 13.25 gm/dl. Mean ESR was 22.6 mm/h. Rise in serum uric acid level was significantly associated with psoriatic arthritis. Conclusion Pakistani patients with psoriasis are more likely to have a lower hemoglobin and a raised ESR. Rise in serum uric acid level is associated with joint involvement.References
Pietrzak A, Michalak-Stoma A, Chowdoroska G, Szapietowski J. Lipid disturbances in psoriasis: An update. Mediators Inflamm. 2010; doi:10.115/2010/535612.
Dogra S, Yadav S. Psoriasis in India: Prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76:595-601.
Gelfand JM, Weinstein R, Porter SB et al. Prevalence and treatment of psoriasis in United Kingdom: a population-based study. Arch Dermatol. 2005;141:1537-41.
Augustin M, Glaeske G, Radtke MA et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162:633-6.
Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157:68-73.
Prodanovich S, Kirsner RS, Kravetz JD et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145:700-3.
Bajaj DR, Mahesar SM, Ghani MH. Hemoglobin content and sedimentation properties of erythrocytes in psoriasis. J Pak Assoc Dermatol. 2008;18:132-7.
Nasreen S, Ahmed I, Effendi S. Frequency and magnitude of anxiety and depression in patients with psoriasis vulgaris. J Coll Physicians Surg Pak. 2008;18:397-400.
Naqqash S, Deen T, Naqqash S, Butt AQ. Family history of psoriasis and recent infectious disease are risk factors for the first episode of acute guttate psoriasis. J Pak Assoc Dermatol. 2004;14:123-8.
Khan GA, Malik LM, Jahangir M. Prevalence of smoking, alcohol, and comorbid conditions in psoriasis. J Pak Assoc Dermatol. 2010;20:212-6.
Bajaj DR, Mahesar SM, Devrajani BR, Iqbal MP. Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad. J Pak Med Assoc. 2009;59:512-5.
Ahmed I, Nasreen S. Frequency and pattern of nail changes in patients with psoriasis vulgaris. J Pak Assoc Dermatol. 2009;19:149-9.
Kim GW, Park HJ, Kim HS et al. Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis. Ann Dermatol. 2012;24:11-5.
Moghaddassi M, Shahram F, Chams-Davatchi C et al. Different aspects of psoriasis: analysis of 150 Iranian patients. Arch Iran Med. 2009;12:279-83.
Saeed M, Zaman T, Rashid T, Jahangir M. Evaluation of joint involvement in patients of psoriasis: an observational study. J Pak Assoc Dermatol. 2008;18:6-8.
Ejaz A, Raza N, Iftikhar N et al. Presentation of early onset psoriasis in comparison with late onset psoriasis: A clinical study from Pakistan. Indian J Dermatol Venereol Leprol. 2009;75:36-40.
Kanelleas A, Liapi C, Katoulis A et al. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept. Clin Exp Dermatol. 2011;36:845-50.
Kwon HH, Kwon IH, Choi JW, Youn JI. Cross-sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis. Clin Exp Dermatol. 2011;36:473-8.
Mahesar SM, Khuhawar MY, Dahot MU. Variation profile of urea and uric acid in normal and psoriatic subjects. Med Channel. 2001;7:23-30.